Insider trade

CEO received an award of 272 PG derivative securities

Traded Aug 6, 2026 · Filed Aug 10, 2026

Procter & GamblePG

272
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 6, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 10, 2026

CEOGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000080424-26-000113
Filed / recorded

Aug 10, 2026, 8:24 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

PROCTER & GAMBLE Co

Issuer CIK

80424

Ticker

PG

Reporting person

Paul Gama

Relationship

Officer

Officer title

CEO- Health Care

Security

Restricted Stock Units

Table

Derivative (Table II)

Transaction date

Aug 6, 2026

Transaction code

A

Shares / units

272

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

272

Ownership form

Direct

Amendment

No

Footnotes from the filing

Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2026.
These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.